Ibilul Cream contains Luliconazole 1% w/w, a broad-spectrum antifungal agent belonging to the imidazole class. It is indicated for the topical treatment of superficial fungal infections of the skin, including tinea corporis, tinea cruris, and tinea pedis caused by dermatophytes such as Trichophyton species. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Ibilul Cream is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. The formulation is well-tolerated, with minimal local adverse effects such as mild burning, itching, or irritation reported in some patients. It is contraindicated in individuals with known hypersensitivity to luliconazole or any excipients present in the cream. Caution is advised when applying near mucous membranes or broken skin. Ibilul Cream offers an effective and convenient treatment option for dermatophytic infections, promoting rapid resolution and reducing the risk of recurrence when used as directed under medical supervision.